% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Alwers:177325,
author = {E. Alwers$^*$ and P. Carr$^*$ and B. Banbury and V.
Walter$^*$ and J. Chang-Claude$^*$ and L. Jansen$^*$ and D.
A. Drew and E. Giovannucci and H. Nan and S. I. Berndt and
W.-Y. Huang and A. Prizment and R. B. Hayes and L. C. Sakoda
and E. White and J. Labadie and M. Slattery and R. E. Schoen
and B. Diergaarde and B. van Guelpen and P. T. Campbell and
U. Peters and A. T. Chan and P. A. Newcomb and M.
Hoffmeister$^*$ and H. Brenner$^*$},
title = {{S}moking {B}ehavior and {P}rognosis {A}fter {C}olorectal
{C}ancer {D}iagnosis: {A} {P}ooled {A}nalysis of 11
{S}tudies.},
journal = {JNCI cancer spectrum},
volume = {5},
number = {5},
issn = {2515-5091},
address = {Oxford},
publisher = {Oxford University Press},
reportid = {DKFZ-2021-02437},
pages = {pkab077},
year = {2021},
note = {#EA:C070#LA:C070#},
abstract = {Smoking has been associated with colorectal cancer (CRC)
incidence and mortality in previous studies, but current
evidence on smoking in association with survival after CRC
diagnosis is limited.We pooled data from 12 345 patients
with stage I-IV CRC from 11 epidemiologic studies in the
International Survival Analysis in Colorectal Cancer
Consortium. Cox proportional hazards regression models were
used to evaluate the associations of prediagnostic smoking
behavior with overall, CRC-specific, and non-CRC-specific
survival.Among 12 345 patients with CRC, 4379 $(35.5\%)$
died (2515 from CRC) over a median follow-up time of 7.5
years. Smoking was strongly associated with worse survival
in stage I-III patients, whereas no association was observed
among stage IV patients. Among stage I-III patients, clear
dose-response relationships with all survival outcomes were
seen for current smokers. For example, current smokers with
40 or more pack-years had statistically significantly worse
overall, CRC-specific, and non-CRC-specific survival
compared with never smokers (hazard ratio [HR] =1.94, $95\%$
confidence interval [CI] =1.68 to 2.25; HR = 1.41, $95\%$ CI
= 1.12 to 1.78; and HR = 2.67, $95\%$ CI = 2.19 to 3.26,
respectively). Similar associations with all survival
outcomes were observed for former smokers who had quit for
less than 10 years, but only a weak association with
non-CRC-specific survival was seen among former smokers who
had quit for more than 10 years.This large consortium of CRC
patient studies provides compelling evidence that smoking is
strongly associated with worse survival of stage I-III CRC
patients in a clear dose-response manner. The detrimental
effect of smoking was primarily related to noncolorectal
cancer events, but current heavy smoking also showed an
association with CRC-specific survival.},
cin = {C070 / C120 / HD01 / C020},
ddc = {610},
cid = {I:(DE-He78)C070-20160331 / I:(DE-He78)C120-20160331 /
I:(DE-He78)HD01-20160331 / I:(DE-He78)C020-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:34738070},
pmc = {pmc:PMC8561259},
doi = {10.1093/jncics/pkab077},
url = {https://inrepo02.dkfz.de/record/177325},
}